SATURDAY, OCTOBER 1, 2016

Mymetics Corp. HIV vaccine candidate shows potential

A recent study of a Mymetics Corp. HIV vaccine candidate showed that it generated significant protection against repeated AIDS virus exposures in groups of 12 female monkeys. Read More »

Study shows flu vaccine distribution model needs improvement

Research from Washington University in St. Louis’ Olin Business School demonstrates that the distribution and delivery system for influenza vaccines needs to be improved to avoid shortages. Read More »

Some patients develop corneal inflammation from chickenpox vaccine

Scientists from the University of Missouri School of Medicine recently discovered  there are rare cases where the varicella zoster virus vaccine, which is meant to protect people from chickenpox and shingles, causes corneal inflammation. Read More »

Missouri scientists create influenza vaccine for infants

Scientists from the University of Missouri School of Medicine have used a natural protein to develop an influenza vaccine that could prevent babies under 6 months old from contracting the flu. Read More »

Sierra Leone workers issue new guidelines for treating children with Ebola

Health care workers based in Port Loko, Sierra Leone, at the biggest Ebola treatment unit, have created guidelines that will help health care professionals to better treat children who have Ebola. Read More »

Parasitic worm increases susceptibility to TB infections

Researchers from Washington University School of Medicine in St. Louis recently conducted a study that demonstrates how an infection from a parasitic worm can make people more susceptible to contracting tuberculosis (TB) infections. Read More »

Washington University study finds possible Chikungunya virus antibodies

Antibodies also neutralize HIV, influenza and hepatitis C. Read More »

Study suggests one vaccine may prevent chikungunya and similar viruses

Scientists from Washington University School of Medicine in St. Louis recently found broadly neutralizing antibodies that could be used to create one vaccine to protect people from chikungunya and its related viruses. Read More »

Saint Louis University receives NIH contract for omics research

The Vaccine and Treatment Evaluation Unit of Saint Louis University recently gained a contract with the National Institutes of Health for the scientists’ “omics” research initiative, which studies the efficacy and safety of vaccines and similar methods of fighting infectious diseases. Read More »

Washington University researchers devise approach to improve immunity

Researchers from the Washington University School of Medicine in St. Louis recently discovered a new approach to improve innate immune defenses while also fighting the virus. Read More »

University of Missouri researchers discover how IFITM proteins block HIV cell-to-cell transmission

Researchers at the University of Missouri have gained an unprecedented level of understanding in how Interferon Induced Transmembranes (IFITM) proteiens serve an antiviral function and help inhibit HIV. Read More »

Researchers develop test to detect virtually any virus

A new test that can detect virtually any virus that could infect any human or animal has been developed at Washington University School of Medicine in St. Louis. Read More »

Crime scene compound may treat malaria

Detectives use a compound to spray crime scenes for trace amounts of blood, and in the future this compound may be used to kill the parasite that causes malaria. Read More »

Diagnostic test created for enterovirus D68

Scientists at Washington University School of Medicine in St. Louis, Missouri, recently created a diagnostic test that rapidly detects enterovirus D68 (EV-D68), which is a respiratory virus. Read More »

Competitive nature may be key to controlling drug-resistant bacteria

A recent study proposes that antibiotic-resistant  “superbugs” may be controlled without creating new antibiotics. Read More »

GenVec teaming up with Washington University on creating targeted adenovector-based therapeutics and vaccines

GenVec, Inc. said Wednesday it is partnering with Dr. David T. Curiel and his team at the School of Medicine at Washington University in St. Louis to develop new, highly targeted, adenovector-based therapeutics and vaccines. Read More »

Personalized melanoma vaccine provokes strong immune response

Washington University School of Medicine researchers have discovered that tailored, personalized melanoma vaccines unleash a strong immune response against uniquely mutated tumors. Read More »

Malaria cells release scents to attract mosquitoes

Scientists from Washington University of Medicine in St. Louis have discovered that Plasmodium falciparum, the parasite that causes malaria, releases odors that are attractive to mosquitoes. Read More »

4 strains in flu vaccine prove more effective than 3

Study by Saint Louis University researchers parallel earlier findings. Read More »

Missouri taking measures to stop avian influenza

2 turkey growing facilities test positive for virus Read More »